Global Variome shared LOVD
CYP2C9 (cytochrome P450, family 2, subfamily C, pol...)
LOVD v.3.0 Build 30b [
Current LOVD status
]
Register as submitter
|
Log in
Curator:
Global Variome, with Curator vacancy
View all genes
View CYP2C9 gene homepage
View graphs about the CYP2C9 gene database
Create a new gene entry
View all transcripts
View all transcripts of gene CYP2C9
Create a new transcript information entry
View all variants
View all variants affecting transcripts
View unique variants in gene CYP2C9
View all variants in gene CYP2C9
Full data view for gene CYP2C9
Create a new data submission
View active genomic custom columns
Enable more genomic custom columns
View all individuals
View all individuals with variants in gene CYP2C9
Create a new data submission
View active custom columns
Enable more custom columns
View all diseases
View all diseases associated with gene CYP2C9
Create a new disease information entry
View available phenotype columns
View all screenings
View all screenings for gene CYP2C9
Create a new data submission
View active custom columns
Enable more custom columns
Submit new data
Unique variants in the CYP2C9 gene
CYP2C9 reference haplotypes
The variants shown are described using the NM_000771.3 transcript reference sequence.
Legend
Please note that a short description of a certain column can be displayed when you move your mouse cursor over the column's header and hold it still. Below, a more detailed description is shown per column.
Effect
: The variant's effect on the function of the gene/protein, displayed in the format 'R/C'. R is the value reported by the source (publication, submitter) and this classification may vary between records. C is the value concluded by the curator. Note that in some database the curator uses Summary records to give details on the classification of the variant.Values used: '+' indicating the variant affects function, '+?' probably affects function, '-' does not affect function, '-?' probably does not affect function, '?' effect unknown, '.' effect was not classified.
Reported
: The number of times this variant has been reported in the database.
Exon
: number of exon/intron containing variant; 2 = exon 2, 12i = intron 12, 2i_7i = from intron 2 to intron 7, 8i_9 = intron 8/exon 9 boundary, _1 = 5' to exon 1, 18_ = 3' of exon 18, _1_18_ = encompassing the entire 18-exon gene
DNA change (cDNA)
: description of variant at DNA level, based on a coding DNA reference sequence (following HGVS recommendations); e.g. c.123C>T, c.123_145del, c.123_126dup. For deletions/duplications extending beyond the reference transcript resp. {0}/{2} is used to replace del/dup. Extent of the deletion/duplication should be specified using the genomic description (g.). "-" indicates the variant described on genomic level does not affect the coding DNA reference sequence.
RNA change
: description of variant at RNA level (following HGVS recommendations).
r.123c>u
r.? = unknown
r.(?) = RNA not analysed but probably transcribed copy of DNA variant
r.spl? = RNA not analysed but variant probably affects splicing
r.(spl?) = RNA not analysed but variant may affect splicing
r.0? = change expected to abolish transcription
Protein
: description of variant at protein level (following HGVS recommendations).
p.(Arg345Pro) = change predicted from DNA (RNA not analysed)
p.Arg345Pro = change derived from RNA analysis
p.? = unknown effect
p.0? = probably no protein produced
Haplotype
: haplotype on which variant was found
Classification method
: The method used for the clinical classification of this variant.
All options:
ACMG
ACGS
EAHAD-CFDB
ENIGMA
IARC
InSiGHT
kConFab
other
Clinical classification
: Clinical classification of variant, preferably based on standardised criteria (e.g. ACMG), directed on the clinical consequences as published/submitted, indicated using an enriched system including inheritance: e.g. pathogenic, pathogenic (dominant), pathogenic (recessive), pathogenic (!), pathogenic (maternal), pathogenic (paternal). Standard inheritance is covered by dominant/recessive, imprinting by maternal/paternal. A '!' warns for exceptional circumstances to be explained in the 'Remarks' field (low penetrance, variants pathogenic in heterozygous state only, hypomorphic/hypermorphic variants, protective variants, etc.). Non-disease consequences (e.g. drug metabolism (pharmacogenetics), risk factor, blood group, tasting bitter) are indicated using additions to the benign classification; benign (dominant), benign (recessive), benign (!), etc. The value 'association' is used for variants associated with a phenotype and 'NA' for variants from in vitro/in silico records. NOTE: classification may differ from the opinion of the curator as given in a variant SUMMARY-record or the 'Functional effect concluded'). NOTE: pathogenic/likely pathogenic should go together with "variant (probably) affects function" In ClassFunctional.
All options:
pathogenic
pathogenic (dominant)
pathogenic (recessive)
pathogenic (!)
pathogenic (maternal)
pathogenic (paternal)
likely pathogenic
likely pathogenic (dominant)
likely pathogenic (recessive)
likely pathogenic (!)
likely pathogenic (maternal)
likely pathogenic (paternal)
VUS
VUS (!)
likely benign
likely benign (dominant)
likely benign (recessive)
likely benign (!)
likely benign (maternal)
likely benign (paternal)
benign
benign (dominant)
benign (recessive)
benign (!)
benign (maternal)
benign (paternal)
conflicting
association
NA
DNA change (genomic) (hg19)
: HGVS description of variant at DNA level, based on the genomic (chromosomal) DNA reference sequence; e.g. g.12345678C>T, g.12345679del, g.12345678_12345890dup
DNA change (hg38)
: HGVS description of variant at DNA level, based on the hg38 genomic (chromosomal) eference sequence; e.g. g.12345678C>T, g.12345679del, g.12345678_12345890dup
Published as
: listed only when different from "DNA change"; variant as reported originally (e.g. 521delT). Variants seen in animal models, tested in vitro, predicted from RNA analysis, etc. are described between brackets like c.(456C>G)
ISCN
: description of the variant according to ISCN nomenclature
DB-ID
: database ID of variant, grouping multiple observations of the same variant together, starting with the HGNC gene symbol, followed by an underscore (_) and a six digit number (e.g. DMD_012345). _000000 is used for variants where DNA was not analysed (change predicted from RNA analysis), variants seen in animal models or variants not seen in humans but functionally tested in vitro
Variant remarks
: remarks regarding variant described, e.g. germline mosaicism in mother, 345 kb deletion, muscle RNA analysed, not in 200 control chromosomes tested, on founder haplotype, etc.
Reference
: publication describing the variant submitted, incl. links to OMIM, PubMed or other source, e.g. "den Dunnen ASHG2003 P2346"
ClinVar ID
: ID of variant in ClinVar database
dbSNP ID
: the dbSNP ID
Origin
: Origin of variant/record: Germline = in all cells, De novo = in all cells, but not in either parent, Germline/De novo (untested) = in all cells, parents not tested (use only when De novo is likely, e.g. isolated/sporadic cases with dominant disease), Somatic = present in a subset of cells, but not in either parent, Uniparental disomy = from parental disomy (maternal or paternal), CLASSIFICATION record = submitter only sharing variant classification (note another report may share Individual data), SUMMARY record = master summary record from curator (may link to another database), In vitro (cloned) = data resulting from in vitro functional assays, animal model = data from animal model, Artefact = false positive variant call, DUPLICATE record = variant already described on another chromosome (e.g. unbalanced translocation, duplicating transposition, 2nd fusion transcript, etc.)
All options:
Germline
De novo
Germline/De novo (untested)
Somatic
Uniparental disomy
Uniparental disomy, maternal allele
Uniparental disomy, paternal allele
CLASSIFICATION record
SUMMARY record
In vitro (cloned)
In silico
animal model
Artefact
DUPLICATE record
Unknown
Not applicable
Segregation
: Indicates whether the variant segregates with the phenotype (yes), does not segregate with the phenotype (no) or segregation is unknown (?)
All options:
? = unknown
yes = segregates with phenotype
no = does not segregate with phenotype
- = not applicable
Frequency
: frequency in which the variant was found; e.g 5/760 chromosomes (in 5 of 760 chromosomes tested), 1/33 patients (in 1 of 33 patients analysed in study), 0.05 controls (in 5% of control cases tested)
Re-site
: restriction enzyme recognition site created (+) or destroyed (-); e.g. BglII+;BamHI-
VIP
: variant VIP-status was requested for matchmaking - need collaboration(s) to crack the case - please contact the submitter/curator. NOTE: to get VIP status ask the curator.
Methylation
: result of methylation test; GOM (gain of methylation), LOM (loss of methylation), 30% (30% methylated). NOTE: when several tests were done mention the method as well (e.g. MS-PCR 75%)
How to query this table
All list views have search fields which can be used to search data. You can search for a complete word or you can search for a part of a search term. If you enclose two or more words in double quotes, LOVD will search for the combination of those words only exactly in the order you specify. Note that search terms are case-insensitive and that wildcards such as * are treated as normal text! For all options, like "and", "or", and "not" searches, or searching for prefixes or suffixes, see the table below.
Operator
Column type
Example
Matches
Text
Arg
all entries containing 'Arg'
space
Text
Arg Ser
all entries containing 'Arg' and 'Ser'
|
Text
Arg|Ser
all entries containing 'Arg' or 'Ser'
!
Text
!fs
all entries not containing 'fs'
^
Text
^p.(Arg
all entries beginning with 'p.(Arg'
$
Text
Ser)$
all entries ending with 'Ser)'
=""
Text
=""
all entries with this field empty
=""
Text
="p.0"
all entries exactly matching 'p.0'
!=""
Text
!=""
all entries with this field not empty
!=""
Text
!="p.0"
all entries not exactly matching 'p.0?'
combination
Text
*|Ter !fs
all entries containing '*' or 'Ter' but not containing 'fs'
Date
2020
all entries matching the year 2020
|
Date
2020-03|2020-04
all entries matching March or April, 2020
!
Date
!2020-03
all entries not matching March, 2020
<
Date
<2020
all entries before the year 2020
<=
Date
<=2020-06
all entries in or before June, 2020
>
Date
>2020-06
all entries after June, 2020
>=
Date
>=2020-06-15
all entries on or after June 15th, 2020
combination
Date
2019|2020 <2020-03
all entries in 2019 or 2020, and before March, 2020
Numeric
23
all entries exactly matching 23
|
Numeric
23|24
all entries exactly matching 23 or 24
!
Numeric
!23
all entries not exactly matching 23
<
Numeric
<23
all entries lower than 23
<=
Numeric
<=23
all entries lower than, or equal to, 23
>
Numeric
>23
all entries higher than 23
>=
Numeric
>=23
all entries higher than, or equal to, 23
combination
Numeric
>=20 <30 !23
all entries with values from 20 to 29, but not equal to 23
Some more advanced examples:
Example
Matches
Asian
all entries containing 'Asian', 'asian', including 'Caucasian', 'caucasian', etc.
Asian !Caucasian
all entries containing 'Asian' but not containing 'Caucasian'
Asian|African !Caucasian
all entries containing 'Asian' or 'African', but not containing 'Caucasian'
"South Asian"
all entries containing 'South Asian', but not containing 'South East Asian'
To sort on a certain column, click on the column header or on the arrows. If that column is already selected to sort on, the sort order will be swapped. The column currently sorted on has a darker blue background color than the other columns. The up and down arrows next to the column name indicate the current sorting direction. When sorting on any field other than the default, LOVD will sort secondarily on the default sort column.
78 entries on 1 page. Showing entries 1 - 78.
10 per page
25 per page
50 per page
100 per page
Legend
How to query
Effect
Reported
Exon
DNA change (cDNA)
RNA change
Protein
Haplotype
Classification method
Clinical classification
DNA change (genomic) (hg19)
DNA change (hg38)
Published as
ISCN
DB-ID
Variant remarks
Reference
ClinVar ID
dbSNP ID
Origin
Segregation
Frequency
Re-site
VIP
Methylation
Owner
-/., -?/., ?/.
8
_1
c.-2663_-2662del
-, r.(=)
p.(=), p.=
CYP2C9*11B, CYP2C9*1B, CYP2C9*1D, CYP2C9*2B
-
benign, likely benign, VUS
g.96695777_96695778del
g.94936020_94936021del
-2665delTG
-
CYP2C9_001001
reference haplotype CYP2C9*11B (predicted haplotype),
3 more items
Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee,
PubMed: King 2004
-
-
Germline
-
0.016 (306 chromosomes), 0.10 (306 chromosomes), 1/306 chromosomes
-
-
-
Johan den Dunnen
?/.
1
_1
c.-2251dupA
r.(=)
p.(=)
-
-
VUS
g.96696189dup
g.94936432dup
-
-
CYP2C9_001013
-
PubMed: King 2004
-
-
Germline
-
-
-
-
-
Johan den Dunnen
?/.
1
_1
c.-2163delA
r.(=)
p.(=)
-
-
VUS
g.96696277del
g.94936520del
-
-
CYP2C9_001014
-
PubMed: King 2004
-
-
Germline
-
-
-
-
-
Johan den Dunnen
+/., +?/., -?/., ?/.
10
_1
c.-1911T>C
-, r.(=)
p.(=), p.=
CYP2C9*3, CYP2C9*3A, CYP2C9*3B
-
likely benign, likely pathogenic, pathogenic, VUS
g.96696529T>C
g.94936772T>C
-1912T>C, T-1912C
-
CYP2C9_001007
haplotype CYP2C9*3; expression cloning promoter activity 0.4,
2 more items
Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee,
PubMed: King 2004
,
2 more items
-
-
Germline, Unknown
-
0.020 (306 chromosomes), 0.062 (306 chromosomes), 1/26 cases, 4/26 cases, 4/37 cases, 4/59 cases,
1 more item
-
-
-
Johan den Dunnen
+?/., -?/., ?/.
10
_1
c.-1885C>G
-, r.(=)
p.(=), p.=
CYP2C9*3, CYP2C9*3A, CYP2C9*3B
-
likely benign, likely pathogenic, VUS
g.96696555C>G
g.94936798C>G
-1886C>G, C-1886G
-
CYP2C9_001008
haplotype CYP2C9*3; expression cloning promoter activity 0.4,
2 more items
Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee,
PubMed: King 2004
,
2 more items
-
-
Germline, Unknown
-
0.020 (306 chromosomes), 0.062 (306 chromosomes), 1/26 cases, 4/26 cases, 4/37 cases, 4/59 cases,
1 more item
-
-
-
Johan den Dunnen
?/.
1
_1
c.-1835C>T
r.(=)
p.(=)
-
-
VUS
g.96696605C>T
g.94936848C>T
-1836C>T
-
CYP2C9_001034
-
PubMed: Zhao 2004
-
-
Unknown
-
1/26 cases
-
-
-
Johan den Dunnen
-/., ?/.
5
_1
c.-1565C>T
r.(=)
p.(=)
-
-
benign, VUS
g.96696875C>T
g.94937118C>T
-1566C>T, C-1566T
-
CYP2C9_001021
expression cloning promoter activity 0.9
PubMed: Shintani 2001
,
PubMed: Zhao 2004
-
rs9332096
Unknown
-
1/26 cases, 17/366 chromosomes, 2/37 cases, 8/59 cases, 9/366 chromosomes
-
-
-
Johan den Dunnen
+?/., -?/., ?/.
10
_1
c.-1537G>A
-, r.(=)
p.(=), p.=
CYP2C9*3, CYP2C9*3A, CYP2C9*3B
-
likely benign, likely pathogenic, VUS
g.96696903G>A
g.94937146G>A
-1538G>A, G-1538A
-
CYP2C9_001009
haplotype CYP2C9*3; expression cloning promoter activity 0.4,
2 more items
Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee,
PubMed: King 2004
,
2 more items
-
-
Germline, Unknown
-
0.020 (306 chromosomes), 0.062 (306 chromosomes), 1/26 cases, 4/26 cases, 4/37 cases, 4/59 cases,
1 more item
-
-
-
Johan den Dunnen
-/., -?/., ?/.
26
_1
c.-1188C>T
-, r.(=)
p.(=), p.=
CYP2C9*11B, CYP2C9*1B, CYP2C9*1C, CYP2C9*2A, CYP2C9*2B
-
benign, likely benign, VUS
g.96697252C>T
g.94937495C>T
-1189C>T, C-1189T
-
CYP2C9_001002
9 more items
Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee,
PubMed: King 2004
,
2 more items
-
rs4918758
Germline, Unknown
-
0.016 (306 chromosomes), 0.075 (306 chromosomes), 0.10 (306 chromosomes), 1/3 cases, 1/306 chromosomes,
10 more items
-
-
-
Johan den Dunnen
-?/., ?/.
2
_1
c.-1188T>C
-, r.(=)
p.(=), p.=
CYP2C9*3B
-
likely benign, VUS
g.96697252T>C
g.94937495T>C
-
-
CYP2C9_001002
reference haplotype CYP2C9*3B (predicted haplotype)
Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee,
PubMed: King 2004
-
rs4918758
Germline
-
0.062 (306 chromosomes)
-
-
-
Johan den Dunnen
-?/., ?/.
6
_1
c.-1096G>A
-, r.(=)
p.(=), p.=
CYP2C9*2A, CYP2C9*2B, CYP2C9*2C
-
likely benign, VUS
g.96697344G>A
g.94937587G>A
-
-
CYP2C9_001003
4 more items
Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee,
PubMed: King 2004
-
-
Germline
-
0.016 (306 chromosomes), 0.10 (306 chromosomes), 1/306 chromosomes
-
-
-
Johan den Dunnen
-?/., ?/.
10
_1
c.-981G>A
-, r.(=)
p.(=), p.=
CYP2C9*3, CYP2C9*3A, CYP2C9*3B
-
likely benign, VUS
g.96697459G>A
g.94937702G>A
-982G>A, G-982A
-
CYP2C9_001010
haplotype CYP2C9*3; expression cloning promoter activity 0.4,
2 more items
Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee,
PubMed: King 2004
,
2 more items
-
-
Germline, Unknown
-
0.020 (306 chromosomes), 0.062 (306 chromosomes), 1/26 cases, 4/26 cases, 4/37 cases, 4/59 cases,
1 more item
-
-
-
Johan den Dunnen
?/.
1
_1
c.-742C>T
r.(=)
p.(=)
-
-
VUS
g.96697698C>T
g.94937941C>T
-
-
CYP2C9_001035
-
PubMed: Zhao 2004
-
-
Unknown
-
2/59 cases
-
-
-
Johan den Dunnen
?/.
1
_1
c.-633delT
r.(=)
p.(=)
-
-
VUS
g.96697807del
g.94938050del
-
-
CYP2C9_001036
-
PubMed: Zhao 2004
-
-
Unknown
-
2/37 cases
-
-
-
Johan den Dunnen
-?/., ?/.
10
_1
c.-620G>T
-, r.(=)
p.(=), p.=
CYP2C9*2A, CYP2C9*2B, CYP2C9*2C
-
likely benign, VUS
g.96697820G>T
g.94938063G>T
-
-
CYP2C9_001004
reference haplotype CYP2C9*2A (predicted haplotype),
2 more items
Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee,
PubMed: King 2004
,
1 more item
-
-
Germline, Unknown
-
0.016 (306 chromosomes), 0.10 (306 chromosomes), 1/26 cases, 1/3 cases, 1/306 chromosomes
-
-
-
Johan den Dunnen
-?/., ?/.
10
_1
c.-485T>A
-, r.(=)
p.(=), p.=
CYP2C9*2A, CYP2C9*2B, CYP2C9*2C
-
likely benign, VUS
g.96697955T>A
g.94938198T>A
-
-
CYP2C9_001005
reference haplotype CYP2C9*2A (predicted haplotype),
2 more items
Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee,
PubMed: King 2004
,
1 more item
-
-
Germline, Unknown
-
0.016 (306 chromosomes), 0.10 (306 chromosomes), 1/26 cases, 1/3 cases, 1/306 chromosomes
-
-
-
Johan den Dunnen
-?/., ?/.
10
_1
c.-484C>A
-, r.(=)
p.(=), p.=
CYP2C9*2A, CYP2C9*2B, CYP2C9*2C
-
likely benign, VUS
g.96697956C>A
g.94938199C>A
-
-
CYP2C9_001006
reference haplotype CYP2C9*2A (predicted haplotype),
2 more items
Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee,
PubMed: King 2004
,
1 more item
-
-
Germline, Unknown
-
0.016 (306 chromosomes), 0.10 (306 chromosomes), 1/26 cases, 1/3 cases, 1/306 chromosomes
-
-
-
Johan den Dunnen
+?/.
1
_1
c.-162A>G
r.(=)
p.(=)
-
-
likely pathogenic
g.96698278A>G
g.94938521A>G
A-162G
-
CYP2C9_001020
expression cloning promoter activity 0.5
PubMed: Shintani 2001
-
-
Unknown
-
1/366 chromosomes
-
-
-
Johan den Dunnen
-/.
1
1_9
c.=
-
p.=
CYP2C9*1
-
benign
g.=
-
-
-
CYP2C9_000001
reference haplotype CYP2C9*1 (1A)
Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee
-
-
Germline
-
-
-
-
-
Johan den Dunnen
-?/.
1
1
c.8C>A
r.(?)
p.(Ser3Tyr)
-
-
likely benign
g.96698447C>A
g.94938690C>A
-
-
CYP2C9_001041
-
PubMed: Goldstein 2009
-
-
Unknown
?
-
-
-
-
Johan den Dunnen
?/.
1
1
c.55C>A
r.(?)
p.Leu19Ile
CYP2C9*7
-
VUS
g.96698494C>A
g.94938737C>A
-
-
CYP2C9_000007
reference haplotype CYP2C9*7
Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee
-
-
Germline
-
-
-
-
-
Johan den Dunnen
?/.
1
1
c.89C>T
r.(?)
p.Pro30Leu
CYP2C9*21
-
VUS
g.96698528C>T
g.94938771C>T
-
-
CYP2C9_000021
reference haplotype CYP2C9*21
Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee
-
-
Germline
-
-
-
-
-
Johan den Dunnen
?/.
1
1
c.121A>G
r.(?)
p.Asn41Asp
CYP2C9*22
-
VUS
g.96698560A>G
g.94938803A>G
-
-
CYP2C9_000022
reference haplotype CYP2C9*22
Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee
-
-
Germline
-
-
-
-
-
Johan den Dunnen
-?/.
1
1i
c.168+83?
r.(?)
p.(=)
-
-
likely benign
g.?
-
IVS1+83 g.-251A>C
-
CYP2C9_001038
-
PubMed: Goldestein 2009
-
-
Unknown
?
-
-
-
-
Johan den Dunnen
-/., -?/.
5
1i
c.169-14G>C
r.(=)
p.(=)
-
-
benign, likely benign
g.96701601G>C
g.94941844G>C
CYP2C9(NM_000771.4):c.169-14G>C
-
CYP2C9_001028
VKGL data sharing initiative Nederland
PubMed: Zhao 2004
-
-
CLASSIFICATION record, Unknown
-
1/26 cases, 1/3 cases
-
-
-
Johan den Dunnen
,
VKGL-NL_Groningen
?/.
2
2
c.208G>C
r.(?)
p.(Gly70Arg), p.Gly70Arg
CYP2C9*20
-
VUS
g.96701654G>C
g.94941897G>C
-
-
CYP2C9_000020
reference haplotype CYP2C9*20
Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee,
PubMed: Zhao 2004
-
-
Germline, Unknown
-
1/74 chromosomes
-
-
-
Johan den Dunnen
?/.
1
2
c.226G>A
r.(?)
p.Val76Met
CYP2C9*23
-
VUS
g.96701672G>A
g.94941915G>A
-
-
CYP2C9_000023
reference haplotype CYP2C9*23
Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee
-
-
Germline
-
-
-
-
-
Johan den Dunnen
?/.
2
2
c.228G>A
r.(?)
p.(=)
-
-
VUS
g.96701674G>A
g.94941917G>A
V67V
-
CYP2C9_001015
not in 200 control chromosomes
PubMed: Imai 2000
,
PubMed: Zhao 2004
-
-
Unknown
-
2/74 chromosomes
ItaI-
-
-
Johan den Dunnen
+/.
4
2
c.269T>C
r.(?)
p.(Leu90Pro), p.Leu90Pro
CYP2C9*13
-
pathogenic
g.96701715T>C
g.94941958T>C
T269C
-
CYP2C9_000013
no homozygotes, reference haplotype CYP2C9*13
Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee,
PubMed: Si 2004
-
rs72558187
Germline
yes
3/294 chromosomes
-
-
-
Johan den Dunnen
-?/.
2
2i
c.331+73T>C
r.(=)
p.(=)
-
-
likely benign
g.96701850T>C
g.94942093T>C
332-99T>C
-
CYP2C9_001032
-
PubMed: Zhao 2004
-
-
Unknown
-
2/3 cases, 7/26 cases
-
-
-
Johan den Dunnen
?/.
1
3
c.353_362del
r.(?)
p.fs*
CYP2C9*25
-
VUS
g.96701970_96701979del
g.94942213_94942222del
353delAGAAATGGAA
-
CYP2C9_000025
reference haplotype CYP2C9*25
Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee
-
-
Germline
-
-
-
-
-
Johan den Dunnen
+/., ?/.
2
3
c.374G>A
r.(?)
p.(Arg125His), p.Arg125His
CYP2C9*14
-
pathogenic, VUS
g.96701991G>A
g.94942234G>A
-
-
CYP2C9_000014
reference haplotype CYP2C9*14
Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee,
PubMed: Zhao 2004
-
rs72558189
Germline, Unknown
-
1/52 chromosomes
-
-
-
Johan den Dunnen
?/.
1
3
c.374G>T
r.(?)
p.Arg125Leu
CYP2C9*35
-
VUS
g.96701991G>T
g.94942234G>T
-
-
CYP2C9_000035
reference haplotype CYP2C9*35
Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee
-
-
Germline
-
-
-
-
-
Johan den Dunnen
+/.
1
3
c.389C>G
r.(?)
p.Thr130Arg
CYP2C9*26
-
pathogenic
g.96702006C>G
g.94942249C>G
-
-
CYP2C9_000026
reference haplotype CYP2C9*26
Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee
-
-
Germline
-
-
-
-
-
Johan den Dunnen
+/.
1
3
c.395G>A
r.(?)
p.Arg132Gln
CYP2C9*33
-
pathogenic
g.96702012G>A
g.94942255G>A
-
-
CYP2C9_000033
reference haplotype CYP2C9*33
Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee
-
-
Germline
-
-
-
-
-
Johan den Dunnen
+/., +?/., -/., -?/., ?/.
72
3
c.430C>T
r.(430c>u), r.(?)
p.(Arg144Cys), p.Arg144Cys
CYP2C9*1/*2, CYP2C9*2, CYP2C9*2/*3, CYP2C9*2A, CYP2C9*2B, CYP2C9*2C, CYP2C9*35
-
benign, benign (!), NA, pathogenic, VUS
g.96702047C>T
g.94942290C>T
CYP2C9(NM_000771.4):c.430C>T (p.R144C), ex3 C>T (Arg144Cys)
-
CYP2C9_000002
expression cloning, reduced rate of diclofenac metabolism, haplotype CYP2C9*2; 3 homozygotes,
13 more items
IP3 project, submitted, Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee,
5 more items
-
rs1057910
,
rs1799853
CLASSIFICATION record, Germline, In vitro (cloned), Not applicable, Unknown
?
0.016 (306 chromosomes), 0.10 (306 chromosomes), 1/26 cases, 1/3 cases, 1/306 chromosomes,
4 more items
AvaII-
-
-
Johan den Dunnen
,
VKGL-NL_Groningen
,
Jesse Swen
,
Hye Sun Gwak
+/+
1
3
c.449G>A
r.(?)
p.Arg150His
CYP2C9*8
-
pathogenic
g.96702066G>A
g.94942309G>A
-
-
CYP2C9_000008
reference haplotype CYP2C9*8; increased activity
Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee
-
-
Germline
-
-
-
-
-
Johan den Dunnen
?/.
1
3
c.449G>T
r.(?)
p.Arg150Leu
CYP2C9*27
-
VUS
g.96702066G>T
g.94942309G>T
-
-
CYP2C9_000027
reference haplotype CYP2C9*27
Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee
-
-
Germline
-
-
-
-
-
Johan den Dunnen
-?/.
1
-
c.458T>C
r.(?)
p.(Val153Ala)
-
-
likely benign
g.96702075T>C
-
CYP2C9(NM_000771.4):c.458T>C (p.V153A)
-
CYP2C9_001044
VKGL data sharing initiative Nederland
-
-
-
CLASSIFICATION record
-
-
-
-
-
VKGL-NL_Groningen
?/.
2
4
c.485C>A
r.(?)
p.(Ser162*), p.Ser162*
CYP2C9*15
-
VUS
g.96707539C>A
g.94947782C>A
-
-
CYP2C9_000015
reference haplotype CYP2C9*15
Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee,
PubMed: Zhao 2004
-
rs72558190
Germline, Unknown
-
1/26 cases
-
-
-
Johan den Dunnen
+/.
4
4
c.541A>C
r.(?)
p.(Ile181Leu)
-
-
pathogenic
g.96707595A>C
g.94947838A>C
527ATT>CTT
-
CYP2C9_001025
-
PubMed: Leung 2001
-
-
Unknown
?
1/89 cases, 2/89 cases, 4/89 cases
-
-
-
Johan den Dunnen
?/.
5
4
c.551A>C
r.(?)
p.(His184Pro)
-
-
VUS
g.96707605A>C
g.94947848A>C
537CAT>CCT
-
CYP2C9_001024
-
PubMed: Leung 2001
-
-
Unknown
?
1/89 cases, 2/89 cases, 4/89 cases
-
-
-
Johan den Dunnen
?/.
7
4
c.575A>C
r.(?)
p.(Gln192Pro)
-
-
VUS
g.96707629A>C
g.94947872A>C
561CAG>CCG
-
CYP2C9_001023
-
PubMed: Leung 2001
-
-
Unknown
?
1/89 cases, 4/89 cases, 6/89 cases
-
-
-
Johan den Dunnen
?/.
1
4
c.610A>C
r.(?)
p.Asn204His
CYP2C9*57
-
VUS
g.96707664A>C
g.94947907A>C
-
-
CYP2C9_000057
reference haplotype CYP2C9*57
Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee
-
-
Germline
-
-
-
-
-
Johan den Dunnen
+/.
12
4
c.622T>G
r.(?)
p.(Leu208Val)
CYP2C9*3
-
pathogenic
g.96707676T>G
g.94947919T>G
608TTG>GTG
-
CYP2C9_001022
-
PubMed: Leung 2001
-
rs72558191
Unknown
?
1/89 cases, 15/89 cases, 2/89 cases, 4/89 cases, 50/89 cases, 6/89 cases
-
-
-
Johan den Dunnen
+/.
1
4
c.641A>T
r.(?)
p.Gln214Leu
CYP2C9*28
-
pathogenic
g.96707695A>T
g.94947938A>T
-
-
CYP2C9_000028
reference haplotype CYP2C9*28
Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee
-
-
Germline
-
-
-
-
-
Johan den Dunnen
?/.
1
5
c.752A>G
r.(?)
p.His251Arg
CYP2C9*9
-
VUS
g.96708974A>G
g.94949217A>G
-
-
CYP2C9_000009
reference haplotype CYP2C9*9
Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee
-
-
Germline
-
-
-
-
-
Johan den Dunnen
?/.
1
5
c.815A>G
r.(?)
p.Glu272Gly
CYP2C9*10
-
VUS
g.96709037A>G
g.94949280A>G
-
-
CYP2C9_000010
reference haplotype CYP2C9*10
Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee
-
-
Germline
-
-
-
-
-
Johan den Dunnen
+/+
1
5
c.818del
r.(?)
p.(Lys273Argfs*34)
CYP2C9*6
-
pathogenic
g.96709040del
g.94949283del
818delA (237fs)
-
CYP2C9_000006
reference haplotype CYP2C9*6; no activity
Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee
-
-
Germline
-
-
-
-
-
Johan den Dunnen
?/.
1
6
c.835C>A
r.(?)
p.Pro279Thr
CYP2C9*29
-
VUS
g.96731876C>A
g.94972119C>A
-
-
CYP2C9_000029
reference haplotype CYP2C9*29
Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee
-
-
Germline
-
-
-
-
-
Johan den Dunnen
?/.
2
6
c.840T>A
r.(?), r.840u>a
p.(=)
-
-
VUS
g.96731881T>A
g.94972124T>A
842G>A
-
CYP2C9_001016
cloned cDNA
PubMed: Imai 2000
,
PubMed: Romkes 1991
-
-
Unknown
-
-
-
-
-
Johan den Dunnen
?/.
1
-
c.853G>T
r.(?)
p.(Glu285Ter)
-
-
VUS
g.96731894G>T
g.94972137G>T
CYP2C9(NM_000771.4):c.853G>T (p.E285*)
-
CYP2C9_001043
VKGL data sharing initiative Nederland
-
-
-
CLASSIFICATION record
-
-
-
-
-
VKGL-NL_Rotterdam
+/., ?/.
2
5, 6
c.895A>G
r.(?)
p.(Thr299Ala)
-
-
pathogenic, VUS
g.96731936A>G
g.94972179A>G
-
-
CYP2C9_001029
-
PubMed: Yuan 2005
,
PubMed: Zhao 2004
-
rs72558192
Unknown
?
1/108 chromosomes, 1/16 patients
-
-
-
Johan den Dunnen
?/.
1
6
c.895G>A
-
p.Thr299Ala
CYP2C9*16
-
VUS
g.96731936G>A
g.94972179G>A
-
-
CYP2C9_000016
1 more item
Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee
-
-
Germline
-
-
-
-
-
Johan den Dunnen
-?/.
1
6i
c.962-32T>C
r.(=)
p.(=)
-
-
likely benign
g.96740908T>C
g.94981151T>C
-
-
CYP2C9_001033
-
PubMed: Zhao 2004
-
-
Unknown
-
1/26 cases
-
-
-
Johan den Dunnen
?/.
1
-
c.964A>G
r.(?)
p.(Lys322Glu)
-
-
VUS
g.96740942A>G
-
CYP2C9(NM_000771.4):c.964A>G (p.(Lys322Glu))
-
CYP2C9_001045
VKGL data sharing initiative Nederland
-
-
-
CLASSIFICATION record
-
-
-
-
-
VKGL-NL_Leiden
?/.
1
7
c.980T>C
r.(?)
p.Ile372Thr
CYP2C9*31
-
VUS
g.96740958T>C
g.94981201T>C
-
-
CYP2C9_000031
reference haplotype CYP2C9*31
Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee
-
rs57505750
Germline
-
-
-
-
-
Johan den Dunnen
+/+, +/., ?/.
7
7
c.1003C>T
r.(?)
p.(Arg335Trp), p.Arg335Trp
CYP2C9*11, CYP2C9*11A, CYP2C9*11B
-
NA, pathogenic, VUS
g.96740981C>T
g.94981224C>T
42542C>T, g.42549C>T
-
CYP2C9_000011
haplotype CYP2C9*11; both 11A and 11B, reference haplotype CYP2C9*11 (11A); decreased activity,
2 more items
Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee,
PubMed: King 2004
,
1 more item
-
rs28371685
Germline, In vitro (cloned), Unknown
?
1/306 chromosomes, 2/106 controls, 2/306 chromosomes, 4/192 patients
-
-
-
Johan den Dunnen
?/.
1
7
c.1004G>A
r.(?)
p.Arg335Gln
CYP2C9*34
-
VUS
g.96740982G>A
g.94981225G>A
-
-
CYP2C9_000034
reference haplotype CYP2C9*34
Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee
-
-
Germline
-
-
-
-
-
Johan den Dunnen
?/.
1
7
c.1060G>A
r.(?)
p.Glu354Lys
CYP2C9*24
-
VUS
g.96741038G>A
g.94981281G>A
-
-
CYP2C9_000024
reference haplotype CYP2C9*24
Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee
-
-
Germline
-
-
-
-
-
Johan den Dunnen
+?/., -/., ?/.
3
7
c.1073A>G
r.(?), r.1073a>g
p.Tyr358Cys
-
-
NA, VUS
g.96741051A>G
g.94981294A>G
-
-
CYP2C9_001019
cloned cDNA, yeast expression cloning modest increase warfarin clearance (3.5 fold increased Vmax),
1 more item
PubMed: Sullivan-Klose 1996
,
PubMed: Umbenhauer 1987
,
PubMed: Ged 1988
-
-
In vitro (cloned), Unknown
-
-
-
-
-
Johan den Dunnen
+/., +?/., ?/.
58
7
c.1075A>C
r.(?), r.1075a>c
p.(Ile359Leu), p.(Ile359Lys), p.Ile359Leu
CYP2C9*1/*3, CYP2C9*18, CYP2C9*2/*3, CYP2C9*3, CYP2C9*3/*3, CYP2C9*3A, CYP2C9*3B
-
benign (!), NA, pathogenic, VUS
g.96741053A>C
g.94981296A>C
ex7 A>C (I359Leu)
-
CYP2C9_000003
cloned cDNA, expression cloning yeast, Km for diclofenac 8x increased/Vmax unchanged, poor metabolizer,
11 more items
IP3 project, submitted, Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee,
9 more items
-
rs1057910
Germline, In vitro (cloned), Unknown
?, yes
0.020 (306 chromosomes), 0.062 (306 chromosomes), 1/100 chromosomes, 1/16 patients, 1/26 cases,
9 more items
-
-
-
Johan den Dunnen
,
Jesse Swen
+?/., ?/.
4
7
c.1076T>C
r.(?)
p.(Ile359Thr), p.Ile359Thr
CYP2C9*4
-
likely pathogenic, NA, VUS
g.96741054T>C
g.94981297T>C
-
-
CYP2C9_000004
expression cloning yeast, Km for diclofenac 2x increased/Vmax 3x decreased,
2 more items
Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee,
PubMed: Ieiri 2000
,
1 more item
-
rs56165452
Germline, In vitro (cloned), Unknown
?
-
-
-
-
Johan den Dunnen
+?/.
1
7
c.1078G>A
r.(?)
p.(Asp360Asn)
-
-
likely pathogenic
g.96741056G>A
g.94981299G>A
-
-
CYP2C9_001040
not in 896 other chromosomes
PubMed: Goldstein 2009
-
-
Unknown
?
-
-
-
-
Johan den Dunnen
+/+, +/.
4
7
c.1080C>G
r.(?)
p.(Asp360Glu), p.Asp360Glu
CYP2C9*5
-
NA, pathogenic
g.96741058C>G
g.94981301C>G
C1080G
-
CYP2C9_000005
expression cloning, catalytic efficiency 0.10 for S-warfarin, diclofenac and lauric acid,
2 more items
Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee,
PubMed: Dickmann 2001
-
rs28371686
Germline, In vitro (cloned), Unknown
?
4/120 chromosomes
-
-
-
Johan den Dunnen
+/., ?/.
2
7
c.1144C>T
r.(?)
p.(Pro382Ser), P.Pro382Ser
CYP2C9*17
-
pathogenic, VUS
g.96741122C>T
g.94981365C>T
-
-
CYP2C9_000017
reference haplotype CYP2C9*17
Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee,
PubMed: Zhao 2004
-
-
Germline, Unknown
-
1/108 chromosomes
-
-
-
Johan den Dunnen
+/.
1
7
c.1145C>T
r.(?)
p.(Pro382Leu)
-
-
pathogenic
g.96741123C>T
g.94981366C>T
-
-
CYP2C9_001037
-
PubMed: Yuan 2005
-
-
Unknown
?
1/16 patients
-
-
-
Johan den Dunnen
?/.
2
8
c.1190A>C
r.(?)
p.(Asp397Ala), p.Asp397Ala
CYP2C9*18
-
VUS
g.96745830A>C
g.94986073A>C
-
-
CYP2C9_000018
reference haplotype CYP2C9*18
Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee,
PubMed: Zhao 2004
-
rs72558193
Germline, Unknown
-
1/74 chromosomes
-
-
-
Johan den Dunnen
+?/., ?/.
3
8
c.1250G>A
r.(?), r.1250g>a
p.Gly417Asp
-
-
NA, VUS
g.96745890G>A
g.94986133G>A
-
-
CYP2C9_001018
cloned cDNA, yeast expression cloning 3.6 fold reduced Vmax for tolbutamide clearance,
1 more item
PubMed: Sullivan-Klose 1996
,
PubMed: Umbenhauer 1987
,
PubMed: Ged 1988
-
-
In vitro (cloned), Unknown
-
-
-
-
-
Johan den Dunnen
?/.
1
8i
c.1291+53A>T
r.(?)
p.(=)
-
-
VUS
g.96745984A>T
g.94986227A>T
-
-
CYP2C9_001017
-
PubMed: Imai 2000
-
-
Unknown
-
-
-
-
-
Johan den Dunnen
?/.
2
9
c.1362G>C
r.(?)
p.(Gln454His), p.Gln454His
CYP2C9*19
-
VUS
g.96748674G>C
g.94988917G>C
-
-
CYP2C9_000019
reference haplotype CYP2C9*19
Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee,
PubMed: Zhao 2004
-
-
Germline, Unknown
-
1/108 chromosomes
-
-
-
Johan den Dunnen
-?/., ?/.
11
9
c.1425A>T
r.(?), r.1425a>u
p.(=), p.=
CYP2C9*18
-
likely benign, VUS
g.96748737A>T
g.94988980A>T
ex9 A>C (p.=), G475G
-
CYP2C9_001012
cloned cDNA, reference haplotype CYP2C9*18
Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee,
PubMed: Imai 2000
,
3 more items
-
-
Germline, Unknown
?
1/26 cases, 4/26 cases, 4/37 cases, 4/59 cases
-
-
-
Johan den Dunnen
+/.
1
9
c.1429G>A
r.(?)
p.Ala477Thr
CYP2C9*30
-
pathogenic
g.96748741G>A
g.94988984G>A
-
-
CYP2C9_000030
reference haplotype CYP2C9*30
Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee
-
-
Germline
-
-
-
-
-
Johan den Dunnen
+/.
1
9
c.1465C>T
r.(?)
p.Pro489Ser
CYP2C9*12
-
pathogenic
g.96748777C>T
g.94989020C>T
-
-
CYP2C9_000012
reference haplotype CYP2C9*12
Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee
-
-
Germline
-
-
-
-
-
Johan den Dunnen
?/.
1
9
c.1468G>T
r.(?)
p.Val490Phe
CYP2C9*32
-
VUS
g.96748780G>T
g.94989023G>T
-
-
CYP2C9_000032
reference haplotype CYP2C9*32
Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee
-
-
Germline
-
-
-
-
-
Johan den Dunnen
?/.
4
9
c.*108C>G
r.(?)
p.(=)
-
-
VUS
g.96748893C>G
g.94989136C>G
1582C>G
-
CYP2C9_001027
-
PubMed: Zhao 2004
-
-
Unknown
-
1/26 cases, 1/3 cases
-
-
-
Johan den Dunnen
?/.
1
9
c.*220A>G
r.(?)
p.(=)
-
-
VUS
g.96749005A>G
g.94989248A>G
1694A>G
-
CYP2C9_001030
-
PubMed: Zhao 2004
-
-
Unknown
-
2/59 cases
-
-
-
Johan den Dunnen
?/.
1
9
c.*268_*269del
r.(?)
p.(=)
-
-
VUS
g.96749053_96749054del
g.94989296_94989297del
1739delAT
-
CYP2C9_001031
-
PubMed: Zhao 2004
-
-
Unknown
-
1/59 cases
-
-
-
Johan den Dunnen
10 per page
25 per page
50 per page
100 per page
Legend
How to query
Screenscraping/webscraping (downloading large amounts of data using scripts) is strictly prohibited.
Use our
APIs
to retrieve data.
Powered by
LOVD v.3.0
Build 30b
LOVD software ©2004-2024
Leiden University Medical Center
Database contents © by their respective submitters and curators